NAT10 and colorectal cancer: Additionally, since 5-fluorouracil (5-Fu) promotes the ubiquitin-mediated degradation of NAT10, a triple combination of 5-Fu, Remodelin, and cetuximab has been shown to be effective in KRAS wild-type colorectal cancer [66].